Suppr超能文献

知情决策:其在癌症筛查中扮演什么角色?

Informed decision making: what is its role in cancer screening?

作者信息

Rimer Barbara K, Briss Peter A, Zeller Paula K, Chan Evelyn C Y, Woolf Steven H

机构信息

Department of Health Behavior and Health Education, School of Public Health, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA.

出版信息

Cancer. 2004 Sep 1;101(5 Suppl):1214-28. doi: 10.1002/cncr.20512.

Abstract

Interest in informed decision making (IDM) has grown in recent years. Greater patient involvement in decision making is consistent with recommendations to improve health care quality. This report provides an overview of IDM; clarifies the differences between IDM, shared decision making (SDM), and informed consent; and reviews the evidence to date about IDM for cancer screening. The authors also make recommendations for research. We define IDM as occurring when an individual understands the disease or condition being addressed and comprehends what the clinical service involves, including its benefits, risks, limitations, alternatives, and uncertainties; has considered his or her preferences and makes a decision consistent with them; and believes he or she has participated in decision making at the level desired. IDM interventions are used to facilitate informed decisions. The authors reviewed the evidence to date for IDM and cancer screening based primarily on published meta-analyses and a recent report for the Centers for Disease Control and Prevention's Guide to Community Preventive Services. IDM and SDM interventions, such as decision aids, result in improved knowledge, beliefs, risk perceptions, and combinations of these. Little or no evidence exists, however, regarding whether these interventions result in 1) participation in decision making at a level consistent with patient preferences or 2) effects on patient satisfaction with the decision-making process. These variables generally either were not assessed or were not reported in the articles reviewed. Results of interventions on uptake of screening were variable. After exposure to IDM/SDM interventions, most studies showed small decreases in prostate cancer screening, whereas four studies on breast and colorectal cancer screening showed small increases. Few data are available by which to evaluate current practices in cancer screening IDM. Patient participation in IDM should be facilitated for those who prefer it. More research is needed to assess the benefits of IDM/SDM interventions and to tailor interventions to individuals who are most likely to desire and benefit from them. There are many system barriers to IDM/SDM and few tools. More work is needed in this area as well. In addition, research is needed to learn how to incorporate IDM into ongoing clinical practice and to determine whether there are unintended negative consequences of IDM.

摘要

近年来,人们对知情决策(IDM)的兴趣与日俱增。患者更多地参与决策符合改善医疗质量的建议。本报告概述了知情决策;阐明了知情决策、共同决策(SDM)和知情同意之间的差异;并回顾了迄今为止有关癌症筛查知情决策的证据。作者还提出了研究建议。我们将知情决策定义为:个体了解所讨论的疾病或状况,理解临床服务的内容,包括其益处、风险、局限性、替代方案和不确定性;考虑了自己的偏好并做出与其一致的决定;并且认为自己已按照期望的程度参与了决策。知情决策干预措施用于促进明智的决策。作者主要基于已发表的荟萃分析以及疾病控制与预防中心《社区预防服务指南》的最新报告,回顾了迄今为止有关知情决策和癌症筛查的证据。知情决策和共同决策干预措施,如决策辅助工具,可提高知识水平、信念、风险认知以及这些方面的综合水平。然而,几乎没有证据表明这些干预措施是否会导致:1)以与患者偏好一致的程度参与决策;或2)对患者对决策过程的满意度产生影响。这些变量在 reviewed 的文章中通常要么未被评估,要么未被报告。关于筛查接受情况的干预结果各不相同。在接触知情决策/共同决策干预措施后,大多数研究表明前列腺癌筛查略有下降,而四项关于乳腺癌和结直肠癌筛查的研究表明略有增加。几乎没有数据可用于评估癌症筛查知情决策的当前实践情况。对于那些愿意参与知情决策的人,应促进其参与。需要更多研究来评估知情决策/共同决策干预措施的益处,并针对最有可能渴望并从中受益的个体量身定制干预措施。知情决策/共同决策存在许多系统障碍,且工具很少。这一领域也需要更多的工作。此外,需要进行研究以了解如何将知情决策纳入正在进行的临床实践,并确定知情决策是否存在意外的负面后果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验